PubMed=8689637; DOI=10.1016/0304-3835(96)04274-7
Jagasia A.A., Block J.A., Qureshi A., Diaz M.O., Nobori T., Gitelis S., Iyer A.P.
Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
Cancer Lett. 105:91-103(1996)

PubMed=10632461; DOI=10.1002/jor.1100170619
Wyman J.J., Hornstein A.M., Meitner P.A., Mak S., Verdier P., Block J.A., Pan J., Terek R.M.
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.
J. Orthop. Res. 17:935-940(1999)

PubMed=10906887; DOI=10.1097/00003086-200007000-00038
Scully S.P., Berend K.R., Toth A., Qi W.-N., Qi Z., Block J.A.
Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma.
Clin. Orthop. Relat. Res. 376:291-303(2000)

PubMed=11854598; DOI=10.1097/00019606-200203000-00005
Lin C.-Z., Meitner P.A., Terek R.M.
PTEN mutation is rare in chondrosarcoma.
Diagn. Mol. Pathol. 11:22-26(2002)

PubMed=12168675; DOI=10.1016/S0736-0266(01)00172-3
Ghert M.A., Qi W.-N., Erickson H.P., Block J.A., Scully S.P.
Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
J. Orthop. Res. 20:834-841(2002)

PubMed=12354749
Martin J.A., Forest E., Block J.A., Klingelhutz A.J., Whited B., Gitelis S., Wilkey A., Buckwalter J.A.
Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.
Cell Growth Differ. 13:397-407(2002)

PubMed=15547702; DOI=10.3892/ijo.25.6.1651
Schorle C.M., Verdorfer I., Finger F., Block J.A., Gebhart E., Aigner T.
Comparative analysis of imbalances in genomic DNA and mRNA expression levels in chondrosarcoma-derived cell line FSCP-1.
Int. J. Oncol. 25:1651-1660(2004)